Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines

Journal of Clinical Pathology - Molecular Pathology

Volumn 55, Issue 5, 2002, Pages 310-314

  Derenzini, M ^a   Montanaro, L ^a   Trere D ^a   Chilla A ^a   Tazzari, P L ^b   Dall'Olio, F ^a   Ofner D ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDYLATE SYNTHASE;

ANTIBODY LABELING; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL CYCLE; CELL CYCLE S PHASE; CELL LINE; CELL PROLIFERATION; CLINICAL ARTICLE; DNA DETERMINATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

CELL CYCLE; CELL DIVISION; HUMANS; KI-67 ANTIGEN; PROGNOSIS; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0036796848     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.55.5.310     Document Type: Article

References (20)

1. Danenberg PV. Thymidylate synthetase-a target enzyme in cancer chemotherapy. Biochim Biophys Acta 1977;473:73-92.
2. Danenberg PV, Langenbach RJ, Heidelberger C. Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. Biochemistry 1974;13:926-33.
3. Moertel CG. Chemotherapy of gastrointestinal cancer. N Engl J Med 1978;299:1049-52.
4. van Triest B, Peters GJ. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer. Oncology 1999;57:179-94.
5. Peters GJ, van der Wilt CL, van Triest B, et al. Thymidylate synthase and drug resistance. Eur J Cancer 1995;31A:1299-305.
6. Yamachika T, Nakanishi H, Inada K, et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 1998;82:70-7.
7. Edler D, Kressner U, Ragnhammar P, et al. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Clin Cancer Res 2000;6:488-92.
8. Edler D, Hallstrom M, Johnston PG, et al. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 2000;6:1378-84.
9. Johnston PG, Fisher ER, Rockette HE, et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994;12:2640-7.
10. Takenoue T, Nagawa H, Matsuda K, et al. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol 2000;7:193-8.
11. Haurani FI, Kardinal CG, Biermann WA. Thymidylate synthetase and dihydrofolic acid reductase in the stimulated human lymphocyte. J Cell Physiol 1978;95:49-55.
12. Navalgund LG, Rossana C, Muench AJ, et al. Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem 1980;255:7386-90.
13. Pestalozzi BC, McGinn CJ, Kinsella TJ, et al. Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells. Br J Cancer 1995;71:1151-7.
14. van Triest B, Pinedo HM, van Hensbergen Y, et al. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clin Cancer Res 1999;5:643-54.
15. Derenzini M, Sirri V, Trerè D, et al. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995;73:497-502.
16. Patterson MK. Measurement of growth and viability of cells in culture. Methods Enzymol 1979;58:141-52.
17. Mirjolet JF, Barberi-Heyob M, Merlin JL, et al. Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity. Br J Cancer 1998;78:62-8.
18. Derenzini M, Trerè D, Pession A, et al. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol 2000;191:181-6.
19. Johnston PG, Drake JC, Trepel J, et al. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 1992;52:4306-12.
20. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15.